Increased expression of ERp57/GRP58 is protective against pancreatic beta cell death caused by autophagic failure

Area of Science:

• Cellular Biology
• Metabolic Disease Research
• Molecular Mechanisms of Disease

Background:

• Autophagy is a vital cellular process for maintaining homeostasis, particularly in pancreatic beta cells.
• The precise mechanisms linking autophagic failure to pancreatic beta cell dysfunction remain incompletely understood.
• Understanding these mechanisms is critical for addressing metabolic disorders characterized by beta cell loss.

Purpose of the Study:

• To investigate the molecular changes in pancreatic beta cells resulting from autophagic failure.
• To identify specific proteins whose expression is altered due to defects in the autophagy-related gene 7 (Atg7) in beta cells.
• To elucidate the functional consequences of altered protein expression in the context of autophagic dysfunction.

Main Methods:

• Comparative proteomic analysis using liquid chromatography/mass spectrometry on islets from beta cell-specific Atg7-deficient mice and controls.
• Validation of protein expression changes in rat insulinoma INS-1 cells with inducible Atg7 gene knockdown.
• Functional assays including cell viability assessment and cell cycle analysis following ERp57 suppression via siRNA in Atg7-knockdown cells.

Main Results:

• Increased expression of ERp57/GRP58 was identified in islets of Atg7-deficient mice and Atg7-knockdown INS-1 cells.
• Suppression of ERp57 in Atg7-knockdown cells led to increased cleaved Caspase-3 levels, indicating apoptosis.
• Reduced ERp57 expression resulted in a higher sub-G1 population, signifying cell death, and a decrease in live cells.

Conclusions:

• Elevated ERp57 expression is a consequence of autophagic failure in pancreatic beta cells.
• ERp57 plays a protective role against cell death when autophagy is compromised.
• These findings suggest ERp57 as a potential therapeutic target for preserving beta cell function in conditions of autophagic stress.